Xylem Reports First Quarter 2021 Results

Go back to Xylem Reports First Quarter 2021 Results

Goldman Sachs Upgrades Xylem (XYL) to Neutral

May 5, 2021 9:15 AM EDT

Goldman Sachs analyst Brian Lee upgraded Xylem (NYSE: XYL) from Sell to Neutral with a price target of $107.00 (from $73.00).

The analyst comments "We acknowledge that our negative call here has been wrong, as we believed the company had more revenue downside risk... More

Xylem (XYL) Tops Q1 EPS by 10c, Revenues Beat; Raises FY21 EPS Guidance

May 4, 2021 6:57 AM EDT

Xylem (NYSE: XYL) reported Q1 EPS of $0.48, $0.10 better than the analyst estimate of $0.38. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.17 billion.

Our Xylem team performed exceptionally well in the first quarter, despite ongoing pandemic challenges around the world. Im so proud of how the team has served our customers... More